Company Profile
IRIDEX Stock Price, News & Catalysts
- Ticker:
- IRIX
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
0.65 USD (+7.36%)
Close
Last updated: September 17, 2026
20.4M USD
Market cap
Why the stock is moving
As of Sep 17, 2026, IRIX closed up 7.36% at $0.6517. No new same-company headline was identified in the current news window.
Company overview
Ophthalmic Laser Technology Company
Iridex develops, manufactures, and markets laser-based medical systems, delivery devices, and accessories for ophthalmology. Its products are used by eye-care specialists to treat glaucoma, diabetic macular edema, and other retinal diseases.
MicroPulse Technology
The company's proprietary MicroPulse technology divides laser energy into controlled pulses separated by rest periods. This approach is designed to deliver a therapeutic effect while limiting excess heat accumulation and collateral tissue damage in sensitive ocular structures.
Glaucoma Portfolio
Iridex's glaucoma franchise is built around the Cyclo G6 laser system and a recurring portfolio of single-use probes. MicroPulse P3, G-Probe, and G-Probe Illuminate devices enable physicians to apply transscleral laser therapy across different glaucoma treatment settings.
Retina Portfolio
The retina business includes PASCAL, IQ, and OcuLight laser systems together with delivery devices and consumables. These products support treatment of retinal vascular conditions and other sight-threatening diseases in both clinic and operating-room environments.
Global Commercial Model
Iridex sells products directly in the United States and primarily through independent distributors internationally. Its commercial network reaches more than 100 countries and combines capital-equipment placements with recurring revenue from procedure-specific probes and other consumables.
Future catalysts
Recent news
- 01
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of IRIDEX (IRIX)?
IRIDEX (IRIX) most recently closed at 0.65 USD, a +7.36% move versus the previous session.
What is the market cap of IRIDEX (IRIX)?
IRIDEX currently has a market capitalization of 20.4M USD on BioPharmSignal.
What does IRIDEX do?
Ophthalmic Laser Technology Company Iridex develops, manufactures, and markets laser-based medical systems, delivery devices, and accessories for ophthalmology. Its products are used by eye-care specialists to treat glaucoma, diabetic macular edema, and other retinal diseases. MicroPulse Technology The company's proprietary MicroPulse technology divides...
On which exchange is IRIX stock listed?
IRIDEX (IRIX) is associated with NASDAQ, United States, Biopharma.
What is Ophthalmic?
Ophthalmic Laser Technology Company Iridex develops, manufactures, and markets laser-based medical systems, delivery devices, and accessories for ophthalmology.
Which conditions is IRIDEX targeting with Ophthalmic?
IRIDEX is associated with ophthalmology based on its company overview and current catalyst commentary.
What is Laser?
Ophthalmic Laser Technology Company Iridex develops, manufactures, and markets laser-based medical systems, delivery devices, and accessories for ophthalmology.
What is Technology?
Ophthalmic Laser Technology Company Iridex develops, manufactures, and markets laser-based medical systems, delivery devices, and accessories for ophthalmology.